Status:
COMPLETED
Effects of Linagliptin on Active GLP-1 Concentrations in Subjects With Renal Impairment
Lead Sponsor:
Profil Institut für Stoffwechselforschung GmbH
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
This is a bi-centric, prospective, open study comparing the effects of linagliptin on active GLP-1 concentrations in subjects with renal impairment compared to subjects with normal renal function.
Eligibility Criteria
Inclusion
- Have Type 2 diabetes mellitus based on the disease diagnostic criteria (WHO) classification
Exclusion
- Subjects with type 1 diabetes, maturity onset diabetes of the young (MODY) or secondary forms of diabetes such as due to pancreatitis.
Key Trial Info
Start Date :
July 11 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2016
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT01903070
Start Date
July 11 2013
End Date
April 1 2016
Last Update
March 3 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Profil Institut für Stoffwechselforschung GmbH
Neuss, North Rhine-Westphalia, Germany, 41460